Is Kimia Biosciences Ltd (530313) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Kimia Biosciences Ltd is a below average quality company .

Is Kimia Biosciences Ltd (530313) undervalued or overvalued?

The key valuation ratios of Kimia Biosciences Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Kimia Biosciences Ltd (530313) share price return in the past 10 years?

Data is not available for this company

Is Kimia Biosciences Ltd (530313) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Kimia Biosciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Kimia Biosciences Ltd (530313)?

Company share prices are keep on changing according to the market conditions. The current trading price of Kimia Biosciences Ltd (530313) on 17-Apr-2026 16:59:59 at 16:59 is 37.97.

What is the P/E ratio of Kimia Biosciences?

The latest standalone P/E ratio of Kimia Biosciences as of 17-Apr-2026 is 18.69.

What is the P/B ratio of Kimia Biosciences Ltd (530313)?

The latest standalone P/B ratio of Kimia Biosciences Ltd (530313) as of 17-Apr-2026 is 10.55.

What is the 52-week high and low of Kimia Biosciences Ltd (530313)?

The 52-week high of Kimia Biosciences Ltd (530313) is Rs. 86.85 and the 52-week low is Rs. 23.20.

Kimia Biosciences Ltd (530313) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Kimia Biosciences Ltd (530313)
Brand: Kimia Biosciences

Kimia Biosciences Ltd (530313) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Kimia Biosciences Ltd (530313)

BSE: 530313 NSE:

Key Metrics

Market Cap

₹180 Cr.

P/E Ratio

18.69

Price to Book (P/B)

10.55

Price to Sales (P/S)

1.51

EV/EBITDA

9.95

Return on Capital Employed (ROCE)

42.18%

Current Price

₹38

Return on Equity (ROE)

186.70%

Return on Assets (ROA)

9.44%

Operating Profit Margin

17%

Net Profit Margin

8.08%

Gross Profit Margin

14.3%

Book Value per Share

₹3.6

Sales Growth (YoY)

13.39%

Sales Growth (3 Years)

-1.62%

Operating Profit Growth (1 Year)

NA%

Operating Profit Growth (3 Years)

217.95%

Net Profit Growth (1 Year)

NA%

52-Week Low / High

₹23 / 87

Net Profit Growth (3 Years)

N/A%

Dividend Yield

0.00%

Promoter Holding

74.94%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Kimia Biosciences Ltd?

Kimia Biosciences Ltd revenue growth is 13.4% for FY-2025 , which is above its 5 year CAGR of 2.3% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Kimia Biosciences Ltd?

Promoters hold 74.94% of the Kimia Biosciences Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Kimia Biosciences Ltd vs industry peers?

Kimia Biosciences Ltd revenue CAGR is 2.27% , compared to the industry median CAGR of 5.54% , indicating slower growth and losing its market share.

Q.1 Which industry/sub-sector does Kimia Biosciences Ltd belong to?

Kimia Biosciences Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1 Stock return of Kimia Biosciences Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of -2.73% based on the current price.

DeciZen - make an informed investing decision on Kimia Biosciences

Based on:

Data

Overall Rating ⓘ
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation ⓘ

3. Price Trend

Kimia Biosciences stock performance

Key Ratios

Is Kimia Biosciences Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	-216.8%	-18.3%	11.8%	16.9%	8.9%	16.1%	-2.3%	-14.3%	-4.2%	42.2%	-
Value Creation Index ⓘ	NA	NA	-0.2	0.2	-0.4	0.2	-1.2	-2.0	-1.3	2.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0.2	1.5	76.3	93.9	106	133	125	129	105	119	119
Sales YoY Gr.	-	668.4%	5,126.7%	23.1%	13.2%	24.9%	-5.9%	2.9%	-18.4%	13.4%	-
Adj EPS ⓘ	-5.5	-1.7	0.9	2.7	0.4	0.9	-0.8	-1.6	-1.1	1.9	2
YoY Gr.	-	NA	NA	189.4%	-85.7%	125.6%	-194.3%	NA	NA	NA	-
BVPS (₹) ⓘ	-5.3	-6.3	-0.2	2.4	2.9	3.9	3.2	1.2	0.1	2.1	3.6
Adj Net Profit ⓘ	-4.1	-1.2	1.4	4	1.8	4.2	-3.9	-7.6	-5.3	9.2	10
Cash Flow from Ops. ⓘ	-6	-0.7	-7.1	-2.7	0.3	6	8	-6.8	14.5	21.3	-
Debt/CF from Ops. ⓘ	-1.1	-13.2	-4.2	-11.6	110	7.5	5.1	-7.8	3	1.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	104.5%	2.3%	-1.6%	13.4%
Adj EPS ⓘ	NA	37.8%	NA	NA
BVPSⓘ	NA	-5.9%	-12.5%	2914.3%
Share Price	-	-1.6%	3.1%	-7.4%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	220.1	29	-117.5	94.7	18.5	26.2	-23.6	-74.7	-181.4	178.7	71.1
Op. Profit Mgn % ⓘ	-1759.4	-56.5	3.2	6.1	4.8	6.3	0.5	-2.8	-0.4	17	14.1
Net Profit Mgn % ⓘ	-2122.9	-84.5	1.8	4.2	1.7	3.1	-3.1	-5.9	-5	7.7	8.1
Debt to Equity ⓘ	-1.7	-2.1	91.2	7.4	2.5	2.4	2.7	9.7	131.1	3.3	-
Working Cap Days ⓘ	1,996	354	102	170	184	179	207	221	250	210	43
Cash Conv. Cycle ⓘ	424	55	45	84	93	88	88	90	73	37	-4

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	2	-
TTM Sales (₹ Cr.)	119	-
BVPS (₹) ⓘ	3.6	-
Reserves (₹ Cr.) ⓘ	12	-
P/BV ⓘ	10.55	-
PE ⓘ	18.69	-

From the Market
52 Week Low / High (₹)	23.20 / 86.85
All Time Low / High (₹)	0.60 / 86.85
Market Cap (₹ Cr.)	180
Equity (₹ Cr.)	4.7
Face Value (₹)	1
Industry PE ⓘ	42.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Kimia Biosciences - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0	1	76	94	106	133	125	129	105	119
Operating Expenses ⓘ +	4	2	74	88	102	124	124	134	105	99
Manufacturing Costs	0	0	3	4	6	9	10	11	8	8
Material Costs	0	0	59	71	80	97	92	96	75	71
Employee Cost	2	1	8	9	11	14	15	16	15	14
Other Costs ⓘ	1	1	4	5	5	5	7	10	7	6
Operating Profit ⓘ	-3	-1	2	6	4	8	1	-5	-0	20
Operating Profit Margin (%)	-1,759.4%	-67.2%	3.2%	5.9%	4.2%	6.3%	0.5%	-4.0%	-0.5%	17.0%
Other Income ⓘ +	0	1	1	1	1	2	1	1	2	1
Exceptional Items ⓘ	0	0	0	0	0	0	0	-1	0	0
Interest ⓘ	1	0	1	2	3	3	4	4	5	5
Depreciation ⓘ	0	0	1	1	2	2	3	3	3	3
Profit Before Tax ⓘ	-4	-1	2	4	1	6	-5	-12	-7	14
Tax ⓘ	0	-0	-0	-0	-0	0	-1	-3	-2	4
Profit After Tax	-4	-1	2	4	1	5	-4	-9	-5	10
PAT Margin (%)	-2,109.8%	-63.7%	2.2%	4.1%	1.3%	3.9%	-3.0%	-7.3%	-5.1%	8.1%
Adjusted EPS (₹)	-5.5	-1.3	1.1	2.6	0.3	1.1	-0.8	-2.0	-1.1	2.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	-4	-5	0	4	13	18	15	5	0	10
Share Capital ⓘ	7	7	2	2	5	5	5	5	5	5
Reserves ⓘ	-11	-12	-2	2	9	14	10	1	-4	5
Debt +	7	9	29	30	31	41	39	51	41	30
Long Term Debt	7	9	25	24	24	28	24	31	21	10
Short Term Debt	0	0	5	5	6	13	15	20	20	20
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0	0	19	18	27	31	40	47	40	50
Others Liabilities ⓘ	1	7	9	14	15	16	14	15	13	19
Total Liabilities ⓘ	4	12	58	65	86	107	109	117	94	109
Fixed Assets
Net Fixed Assets ⓘ +	3	7	13	16	18	28	35	34	32	33
Gross Block	12	7	15	19	22	34	44	46	47	52
Accumulated Depreciation	8	0	2	3	4	6	9	12	16	19
CWIP ⓘ	0	3	2	2	6	6	0	1	1	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0	1	10	16	20	24	37	48	31	35
Trade Receivables	0	0	29	29	37	42	30	31	28	37
Cash Equivalents	0	0	2	1	1	2	1	0	1	1
Others Assets ⓘ	1	1	2	1	3	5	6	4	3	4
Total Assets ⓘ	4	12	58	65	86	107	109	117	94	109

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-6	-1	-7	-3	0	6	8	-7	15	21
PBT ⓘ	-4	-1	2	4	1	6	-5	-12	-7	14
Adjustment ⓘ	1	1	1	1	4	4	6	8	8	7
Changes in Working Capital ⓘ	-3	-0	-10	-8	-5	-3	7	-2	14	1
Tax Paid ⓘ	0	-0	0	-0	0	0	-0	0	0	0
Cash Flow From Investing Activity ⓘ +	-0	-6	-2	-2	-9	-14	-1	-3	-1	-5
Capex	-0	-6	-3	-3	-9	-14	-2	-3	-2	-5
Net Investments	0	0	0	0	0	-0	1	-0	-0	-0
Others ⓘ	0	0	0	0	0	0	0	0	0	-0
Cash Flow From Financing Activity ⓘ +	6	7	10	4	8	8	-8	10	-13	-17
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	7	3	11	4	3	4	-3	7	-9	-11
Interest Paid ⓘ	-1	-0	-1	-1	-1	-2	-3	-3	-4	-6
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	4	-0	1	7	7	-2	5	-0	0
Net Cash Flow ⓘ	0	0	0	-0	0	0	-0	-0	-0	0

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	N/A	N/A	N/A	243.83	16.47	32.19	-22.22	-91.91	N/A	186.7
ROCE (%)	N/A	N/A	N/A	16.94	8.94	16.13	-2.32	-14.3	N/A	42.18
Asset Turnover Ratio	0.04	0.18	2.18	1.52	1.41	1.38	1.16	1.14	0.99	1.17
PAT to CFO Conversion(x)	N/A	N/A	-3.5	-0.75	0	1.2	N/A	N/A	N/A	2.1
Working Capital Days
Receivable Days	346	21	71	114	114	109	105	86	101	99
Inventory Days	143	83	24	50	63	61	89	121	138	100
Payable Days	2,391	260	61	95	101	108	140	165	210	233

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Kimia Biosciences Ltd FAQs

The current trading price of Kimia Biosciences on 17-Apr-2026 16:59 is ₹37.97.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Kimia Biosciences stood at ₹179.7 Cr

The latest P/E ratio of Kimia Biosciences as of 16-Apr-2026 is 18.69.

The latest P/B ratio of Kimia Biosciences as of 16-Apr-2026 is 10.55.

The 52-week high of Kimia Biosciences is ₹86.85 and the 52-week low is ₹23.20.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Kimia Biosciences is ₹119 ( Cr.) .

About Kimia Biosciences Ltd

No data to display

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Kimia Biosciences Ltd (530313) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Kimia Biosciences Share Price